Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.37
-0.11-7.43%
At close: Jun 5, 5:00 PM EST
$1.44
0.075.11%
After Hours: 8:03 AM EST
Traws Pharma Inc Analyst Ratings
TRAWNASDAQ
Traws Pharma Analyst Ratings and Price Targets | NASDAQ:TRAW | Benzinga
Traws Pharma Inc has a consensus price target of $8 based on the ratings of 1 analysts. The high is $8 issued by HC Wainwright & Co. on May 20, 2026. The low is $8 issued by HC Wainwright & Co. on May 20, 2026. The 2 most-recent analyst ratings were released by HC Wainwright & Co. on May 20, 2026 and December 3, 2025, respectively. With an average price target of $8 between HC Wainwright & Co., there's an implied 455.56% upside for Traws Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Traws Pharma
Loading calendar...
FAQ
What is the target price for Traws Pharma (TRAW) stock?
The latest price target for Traws Pharma (NASDAQ:TRAW) was reported by HC Wainwright & Co. on May 20, 2026. The analyst firm set a price target for $8.00 expecting TRAW to rise to within 12 months (a possible 455.56% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Traws Pharma (TRAW)?
The latest analyst rating for Traws Pharma (NASDAQ:TRAW) was provided by HC Wainwright & Co., and Traws Pharma reiterated their buy rating.
When was the last upgrade for Traws Pharma (TRAW)?
There is no last upgrade for Traws Pharma
When was the last downgrade for Traws Pharma (TRAW)?
There is no last downgrade for Traws Pharma.
When is the next analyst rating going to be posted or updated for Traws Pharma (TRAW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Traws Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Traws Pharma was filed on May 20, 2026 so you should expect the next rating to be made available sometime around May 20, 2027.
Is the Analyst Rating Traws Pharma (TRAW) correct?
While ratings are subjective and will change, the latest Traws Pharma (TRAW) rating was a reiterated with a price target of $8.00 to $8.00. The current price Traws Pharma (TRAW) is trading at is $1.44, which is out of the analyst’s predicted range.
